A decision in the case of the UK Anti-Doping (UKAD) v Peter Newman has been published by the National Anti-Doping Panel (NADP).
On 30 September 2018 Peter Newman, a licenced competitor of Motorsport UK, was selected for In-Competition testing following the final round of the 2018 Tuto Money Super One British Karting Championships at the PF International Kart Circuit, Grantham. The urine sample returned an Adverse Analytical Finding for the presence of carboxy-THC, a metabolite of cannabis, which is a Specified substance prohibited In-Competition only.
Mr Newman was subsequently charged with a breach of Anti-Doping Rule Article 2.1 for the Presence of a Prohibited Substance or its Metabolites or Markers. Mr Newman admitted the Anti-Doping Rule Violation (ADRV) and the NADP Tribunal, consisting of Jeremy Summers, Michelle Duncan and Dr Terry Crystal were tasked with determining sanction.
The Tribunal found that UKAD did not establish, to the required burden of proof, that the Athlete had acted intentionally in committing the ADRV. Although the Tribunal found that the ADRV was not intentional, they concluded that Mr Newman had acted with a high degree of Fault, and was not entitled to any reduction in the period of Ineligibility. The Tribunal imposed a period of ineligibility of 2 years, running from 30 September 2018, the date of Sample collection, until midnight on 29 September 2020.
A copy of the full decision can be accessed via the related links tab on the right-hand side.
The National Anti-Doping Panel (NADP) is the United Kingdom’s independent tribunal responsible for adjudicating anti-doping disputes in sport. It is operated by Sport Resolutions and is entirely independent of UK Anti-Doping who is responsible for investigating, charging and prosecuting cases before the NADP.
